Keros Therapeutics, Inc. (KROS)
11.02
+0.03
(+0.27%)
USD |
NASDAQ |
Mar 13, 16:00
11.00
-0.02
(-0.14%)
After-Hours: 20:00
Keros Therapeutics Shareholders Equity (Quarterly) : 303.13M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| MannKind Corp. | -51.02M |
| Sarepta Therapeutics, Inc. | 1.141B |
| PTC Therapeutics, Inc. | -205.31M |
| Insmed, Inc. | 738.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 342.87M |
| Total Liabilities (Quarterly) | 39.74M |
| Debt to Equity Ratio | 0.0557 |
| Current Ratio | 15.45 |
| Net Debt Paydown Yield | 0.12% |